Last reviewed · How we verify
J2H-1702
At a glance
| Generic name | J2H-1702 |
|---|---|
| Sponsor | J2H Biotech |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males (PHASE1)
- Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females (PHASE1)
- Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |